Učitavanje...
Delivery of nucleic acid therapeutics for cancer immunotherapy
Cancer immunotherapy has shown great potential as witnessed by an increasing number of immuno-oncology drug approvals in the past few years. Meanwhile, the field of nucleic acid therapeutics has made significant advancement. Nucleic acid therapeutics, such as plasmids, antisense oligonucleotides (AS...
Spremljeno u:
| Izdano u: | Med Drug Discov |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8320672/ https://ncbi.nlm.nih.gov/pubmed/34337382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medidd.2020.100023 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|